This study investigates pancreatic ductal adenocarcinoma. The purpose of this study is to understand the clinical, epidemiological, and biological profiles of individuals with this condition.
This study evaluates various characteristics of the condition, focusing on understanding different patient profiles and outcomes.
- Who can participate: Adults aged 18 and older with a confirmed or highly suspicious diagnosis of pancreatic ductal adenocarcinoma may participate. Participants must not have received prior treatment for the condition.
- Study details: Participants will provide information and samples to help researchers understand their condition better. An inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine is not used in this study.